RUOZI, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 18.238
EU - Europa 11.154
AS - Asia 2.798
SA - Sud America 46
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 16
Totale 32.301
Nazione #
US - Stati Uniti d'America 18.184
GB - Regno Unito 4.311
IT - Italia 3.042
SE - Svezia 1.222
CN - Cina 1.011
DE - Germania 669
HK - Hong Kong 613
UA - Ucraina 574
TR - Turchia 566
FI - Finlandia 349
SG - Singapore 286
FR - Francia 245
BG - Bulgaria 235
IN - India 92
BE - Belgio 74
IE - Irlanda 74
RO - Romania 71
RU - Federazione Russa 58
NL - Olanda 45
ID - Indonesia 44
CA - Canada 42
LT - Lituania 40
KR - Corea 34
IR - Iran 33
CH - Svizzera 31
ES - Italia 31
VN - Vietnam 28
JP - Giappone 20
BR - Brasile 18
CZ - Repubblica Ceca 18
MY - Malesia 18
EU - Europa 16
GR - Grecia 15
IL - Israele 15
PL - Polonia 14
PT - Portogallo 13
AU - Australia 12
EG - Egitto 11
TW - Taiwan 10
HU - Ungheria 9
CL - Cile 8
CO - Colombia 8
PK - Pakistan 8
SN - Senegal 7
AR - Argentina 6
MX - Messico 6
IQ - Iraq 5
ZA - Sudafrica 5
BZ - Belize 4
NZ - Nuova Zelanda 4
PE - Perù 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AT - Austria 3
DK - Danimarca 3
YE - Yemen 3
AN - Antille olandesi 2
BY - Bielorussia 2
HR - Croazia 2
LK - Sri Lanka 2
MA - Marocco 2
NG - Nigeria 2
RS - Serbia 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CY - Cipro 1
DZ - Algeria 1
EC - Ecuador 1
GH - Ghana 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MT - Malta 1
NO - Norvegia 1
PH - Filippine 1
RE - Reunion 1
Totale 32.301
Città #
Southend 3.817
Fairfield 2.347
Chandler 1.756
Woodbridge 1.635
Ashburn 1.393
Jacksonville 1.261
Houston 1.057
Seattle 977
Dearborn 953
Ann Arbor 918
Wilmington 912
Cambridge 795
Nyköping 775
Hong Kong 602
Modena 499
Beijing 383
Izmir 353
Princeton 249
Sofia 230
Eugene 219
San Diego 208
Chicago 206
Singapore 157
Milan 148
Helsinki 141
New York 138
Des Moines 117
Redwood City 112
Rome 105
London 94
Bremen 93
Falls Church 88
Fremont 87
Bologna 82
Brussels 67
Dublin 60
Shanghai 59
Hefei 52
Florence 45
Boardman 44
Jakarta 41
Como 40
Parma 40
Naples 38
Norwalk 37
Nanjing 36
Reggio Emilia 36
Tulare 33
Napoli 32
Turin 30
Bari 28
Catania 27
Kunming 26
San Giuliano Milanese 26
Los Angeles 25
Frankfurt am Main 24
Jinan 24
Dong Ket 22
Guangzhou 22
Hounslow 21
Verona 18
Kilburn 17
Mountain View 17
Palermo 17
Perugia 17
Saint Petersburg 17
Indiana 16
Kocaeli 16
Padova 16
Phoenix 16
Ferrara 15
Dongguan 14
Genoa 14
Toronto 14
Washington 14
San Mateo 13
Wuhan 13
Brescia 12
Limerick 12
Prescot 12
Sassuolo 12
Auburn Hills 11
Halifax 11
Milwaukee 11
Salerno 11
Bengaluru 10
Brno 10
Carmichael 10
Castelnuovo Di Porto 10
Hangzhou 10
Pescara 10
Amsterdam 9
Cairo 9
Chennai 9
Genova 9
Istanbul 9
Pavia 9
Reggio Nell'emilia 9
Central 8
Changsha 8
Totale 24.337
Nome #
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 363
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 321
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 279
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 279
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 260
Protein corona and nanoparticles: How can we investigate on? 246
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 244
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 238
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 236
Nanoparticle transport across the blood brain barrier 229
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 229
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 225
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 225
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 225
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 221
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 221
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 219
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 215
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 215
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 214
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 210
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 210
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 208
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 208
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 207
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 203
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 202
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 202
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 198
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 197
Amphiphilic Erythromycin-Lipoamino Acid Ion Pairs: Characterization and In Vitro Microbiological Evaluation 195
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 194
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 192
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 192
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 191
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 190
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 189
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 189
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 189
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 187
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 186
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 183
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 182
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 182
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 182
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 182
Colloidal systems for CNS drug delivery 181
The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier 181
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 181
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 180
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 180
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 180
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 179
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 177
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 177
Functionalization of liposomes: microscopical methods for preformulative screening 176
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems 176
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53wildtype JVM-2 But Not Towards p53mutated BJAB Leukemic Cells 175
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 174
Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat 174
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 171
Amphiphilic ion pairs of tobramycin with lipoamino acids 170
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 170
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 170
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 170
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 169
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 169
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 168
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 168
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 167
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 166
Preparazione e caratterizzazione del complesso tra acido iodesossicolico e 2-idrossipropil-beta-ciclodestrina 166
Studi preformulativi sul complesso di inclusione tra acido ursodesossicolico e beta-ciclodestrine 166
Detection of PLGA-based nanoparticles at single cell level by Synchrotron Radiation FTIR Spectromicroscopy and correlation with X-Ray Fluorescence Microscopy 166
STUDIO TECNOLOGICO DI OTTIMIZZAZIONE DI SISTEMI NANOPARTICELLARI ALLESTITI IN EMULSIONE SEMPLICE 165
Polymeric nanoparticles for the drug delivery to the central nervous system 164
Sustained Zero-Order Release of Intact Ultra-Stable Drug-Loaded Liposomes from an Implantable Nanochannel Delivery System 162
Brain-targeted polymeric nanoparticles: in vivo evidences after different routes of administration in rodents. 161
Ketorolac tromethamine liposomes: Encapsulation and release studies 160
Brain targeting with polymeric nanoparticles: which administration route should we take? 160
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 160
Preparation and Microbiological Evaluation of Amphiphilic Kanamycin-Lipoamino Acid Ion-Pairs 159
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 159
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 158
Nanomedicine and neurodegenerative disorders: So close yet so far 157
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 157
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 155
Nanomedicine: the future for advancing medicine and neuroscience 154
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 154
Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier. 152
Interazione tra liposomi cationici e DNA plasmidico: studi di transfezione genica in diverse linee cellulari 152
Synthesis, characterization and in vitro evaluation of amphiphilic ion pairs of erythromycin and kanamycin antibiotics with liposaccharides 151
Preparation, characterization and photostability assessment of curcumin microencapsulated within methacrylic copolymers 151
Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier 150
pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles 150
Evidence of the existence of 2:1 guest-host complexes between diclofenac and cyclodextrins in D2O solutions. A 1H and 13C NMR study on diclofenac/beta-cyclodextrin and diclofenac/2-hydroxypropyl-beta-cyclodextrin systems 149
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 148
Cationic liposomes for gene transfection 148
The bridge between Nanotechnology and Neuroscience: Neuro-Nanomedicine 148
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 148
Totale 18.833
Categoria #
all - tutte 127.929
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.929


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.991 402 410 186 403 824 946 1.160 789 868 292 439 272
2020/20215.893 848 233 449 524 492 362 487 701 255 899 365 278
2021/20224.234 189 486 381 289 161 212 238 229 498 332 698 521
2022/20234.919 592 536 401 482 569 711 116 437 578 91 188 218
2023/20243.460 177 202 220 286 732 356 396 426 127 89 148 301
2024/2025422 422 0 0 0 0 0 0 0 0 0 0 0
Totale 32.701